Regeneron Pharmaceuticals Inc (REGN) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for REGN. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 1,313 institutions reported holding REGN, with 90.2 million shares worth $56.4 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Vanguard | 10,858,192 | $6.8B | INCREASED |
| BlackRock | 9,113,506 | $5.7B | INCREASED |
| Dodge & Cox | 4,871,137 | $3.0B | INCREASED |
| State Street | 4,834,688 | $3.0B | INCREASED |
| Invesco Ltd | 3,940,665 | $2.5B | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Andrew J Murphy (Co-Chief Scientific Officer) | SELL | 50 | $39K | 2026-10-14 |
| Andrew J Murphy (Co-Chief Scientific Officer) | SELL | 463 | $361K | 2026-10-14 |
| Andrew J Murphy (Co-Chief Scientific Officer) | SELL | 380 | $296K | 2026-10-14 |
| Andrew J Murphy (Co-Chief Scientific Officer) | SELL | 454 | $354K | 2026-10-14 |
| Andrew J Murphy (Co-Chief Scientific Officer) | SELL | 38 | $30K | 2026-10-14 |
Recent Congressional Trades
| Member | Type | Amount | Date |
|---|---|---|---|
| Ro Khanna (Democrat) | SALE | $1,001 - $15,000 | 2026-09-04 |
| Ro Khanna (Democrat) | PURCHASE | $1,001 - $15,000 | 2026-07-07 |
Full institutional holdings, insider history, and congressional trades for Regeneron Pharmaceuticals Inc on SentiSense.